Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAT-2003 in hyperlipidemia
NCT01912560Phase 2Completed
- Sponsor
- Astria Therapeutics
- Start
- Jul 2013
- Primary completion
- Dec 2013
- Modality
- Small Molecules, Antibody-Drug Conjugates (ADCs)
- Countries
- 2
01
Overview
A Phase 2 trial of CAT-2003 in hyperlipidemia, hypertriglyceridemia, hypercholesterolemia, sponsored by Astria Therapeutics. Started Jul 2013; status: completed.
02
Drugs
CAT-2003
03
Conditions
hyperlipidemiahypertriglyceridemiahypercholesterolemia
Beyond the preview
Go deeper on NCT01912560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01912560.